NCT05181605 2022-08-09
Survival Analysis After Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer and Risk Factors
Instituto de investigación e innovación biomédica de Cádiz
Phase 2/3 Unknown
Instituto de investigación e innovación biomédica de Cádiz
Alliance for Clinical Trials in Oncology
Centro Ricerche Cliniche di Verona
Fudan University